Dr Charlie Massie

Dr Charlie Massie

Title

Department of Oncology
CRUK Cambridge Centre Early Detection programme

Group Leader
https://www.molecularinformatics.org/

Using genetic and epigenetic alterations found in early prostate cancer Charlie Massie's uro-oncology early detection lab will create assays for sensitive detection and quantification of cell-free tumour DNA and develop molecular prognostic scores to help stratify early stage prostate tumours. More accurate risk stratification will spare men with indolent disease from the risks of unnecessary over treatment, and allow more targeted interventions in men with high-risk disease. Click here for the latest updates on ctDNA and liquid biopsy.

Back to Directory